Nathan Eddy
The grant will help Verily generate a detailed molecular dataset of Parkinson’s disease, integrating genomic, metabolic, immunologic and digital health data.
The grant will help Verily generate a detailed molecular dataset of Parkinson’s disease, integrating genomic, metabolic, immunologic and digital health data.
The partners aim to streamline clinical trials by automating data transfer from electronic health records to trial databases to reduce administrative burdens and accelerate research.
The company will use the funds to scale its technology, expand into new biomarker applications, and advance real-time hydration and metabolic health monitoring.
The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.
The partnership highlights the broader trend of AI-driven innovation in drug discovery and precision medicine.